Publication: Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme: Difference between revisions
Appearance
Created page with "{{Publication |Title=Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme |Topic=Enzymes (bromelain papain) |Author=Stauder, G; Beaufort, F; Streichhan, P |Year=1991 |Journal=Deutsche Zeitschrift für Onkologie |DOI=- |Authors Abstract=In dieser randomisierten, prospektiven klinischen Studie wurden additiv eingesetzte hydrolytische Enzyme bei radiationstherapierten Abdominalkrebspatienten mit alleiniger Strahlen..." |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 5: | Line 5: | ||
|Year=1991 | |Year=1991 | ||
|Journal=Deutsche Zeitschrift für Onkologie | |Journal=Deutsche Zeitschrift für Onkologie | ||
|Authors Abstract=In this randomized prospective clinical trial hydrolytic enzymes were given addionally to radiation in abdominal cancer patients and compared with radiation only. The concomitant oral enzyme therapy improved the tolerance of the radiation significantly. The enzyme treated patients had less deterioration of general condition and skin symptomes and less patients discontinued radiation. It reduced the number of drugs needed for the treatment od radiation avderse effects, especially antiemetics, gastrointestinal drugs, antidepressives, tranquilizers and other psychopharmaceuticals, analgetics, spamolytics, diuretics and aldosteron antagonists. In most cases the enzyme therapy was well or very well tolerated. | |||
|Authors Abstract=In | |||
}} | }} |
Latest revision as of 11:18, 30 September 2024
Reference | |
---|---|
Title | Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme |
Topic | Enzymes (bromelain papain) |
Author | Stauder, G, Beaufort, F, Streichhan, P |
Year | 1991 |
Journal | Deutsche Zeitschrift für Onkologie |
DOI |
Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.
In this randomized prospective clinical trial hydrolytic enzymes were given addionally to radiation in abdominal cancer patients and compared with radiation only. The concomitant oral enzyme therapy improved the tolerance of the radiation significantly. The enzyme treated patients had less deterioration of general condition and skin symptomes and less patients discontinued radiation. It reduced the number of drugs needed for the treatment od radiation avderse effects, especially antiemetics, gastrointestinal drugs, antidepressives, tranquilizers and other psychopharmaceuticals, analgetics, spamolytics, diuretics and aldosteron antagonists. In most cases the enzyme therapy was well or very well tolerated. |
This publication is referenced in the following studies: